Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-127438

Options or other derivatives

  • Chief Operating Officer acquired 47,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2016-06-09 Grant or award · Stock Option (right to buy) +15,600 15,600 D: show line 1 in the form
Keuer Thomas A Chief Operating Officer 2016-06-09 Grant or award · Stock Option (right to buy) +31,700 31,700 D: show line 2 in the form
Loading xslF345X03/doc4.xml…